13.41
前日終値:
$13.32
開ける:
$13.41
24時間の取引高:
3.73M
Relative Volume:
1.65
時価総額:
$3.82B
収益:
$1.16B
当期純損益:
$77.95M
株価収益率:
49.48
EPS:
0.2711
ネットキャッシュフロー:
$144.80M
1週間 パフォーマンス:
-8.49%
1か月 パフォーマンス:
-21.64%
6か月 パフォーマンス:
-16.42%
1年 パフォーマンス:
+18.09%
Sotera Health Co Stock (SHC) Company Profile
名前
Sotera Health Co
セクター
電話
440-262-1410
住所
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Compare SHC vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
SHC
Sotera Health Co
|
13.41 | 3.82B | 1.16B | 77.95M | 144.80M | 0.2711 |
|
TMO
Thermo Fisher Scientific Inc
|
464.37 | 172.51B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
187.32 | 132.46B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
573.82 | 45.69B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.51 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
286.57 | 28.11B | 3.17B | 642.63M | 516.49M | 10.77 |
Sotera Health Co Stock (SHC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-09 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2026-01-09 | 再開されました | RBC Capital Mkts | Outperform |
| 2025-12-18 | 開始されました | William Blair | Outperform |
| 2025-11-13 | 開始されました | BMO Capital Markets | Outperform |
| 2025-05-05 | アップグレード | Goldman | Neutral → Buy |
| 2024-12-06 | 開始されました | Goldman | Neutral |
| 2024-05-21 | 開始されました | Piper Sandler | Neutral |
| 2024-04-03 | アップグレード | Citigroup | Neutral → Buy |
| 2024-03-25 | アップグレード | Jefferies | Hold → Buy |
| 2024-02-06 | 再開されました | KeyBanc Capital Markets | Sector Weight |
| 2023-06-26 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-23 | アップグレード | JP Morgan | Underweight → Neutral |
| 2023-01-11 | アップグレード | Barclays | Underweight → Overweight |
| 2023-01-11 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2022-11-15 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2022-10-05 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-09-26 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-09-21 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2022-09-20 | ダウングレード | Goldman | Buy → Neutral |
| 2022-06-09 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-03-03 | ダウングレード | Jefferies | Buy → Hold |
| 2022-03-02 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2021-01-14 | 開始されました | Robert W. Baird | Outperform |
| 2020-12-15 | 開始されました | Citigroup | Buy |
| 2020-12-15 | 開始されました | Credit Suisse | Outperform |
| 2020-12-15 | 開始されました | Goldman | Buy |
| 2020-12-15 | 開始されました | JP Morgan | Overweight |
| 2020-12-15 | 開始されました | Jefferies | Buy |
| 2020-12-15 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | 開始されました | RBC Capital Mkts | Outperform |
すべてを表示
Sotera Health Co (SHC) 最新ニュース
Sotera Health at Barclays Conference: Strategic Growth and Legal Challenges - Investing.com
Sotera Health Board Member Trades $229.05M In Company Stock - Benzinga
Insider Transaction: WARBURG PINCUS CO Sells $229.05M Worth Of Sotera Health Shares - Benzinga
Warburg Pincus entities cut Sotera Health (SHC) stake with 15M-share sale - Stock Titan
Warburg Pincus amendment: holds 11.2% of Sotera Health (NYSE: SHC) - Stock Titan
Sotera Health Company (NASDAQ:SHC) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Sotera Health stockholders sell 25 million shares in secondary offering - Investing.com India
Sotera Health stockholders sell 25 million shares in secondary offering By Investing.com - Investing.com Canada
Sotera Health Ownership Shift As 25m Share Sale Tests Valuation - simplywall.st
Sotera Health (NASDAQ:SHC) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Wells Fargo Manages Offering for SHC - GuruFocus
Sotera Health shares fall 4.2% as private equity firms launch secondary offering By Investing.com - Investing.com South Africa
Sotera Health shares fall 4.2% as private equity firms launch secondary offering - Investing.com
Sotera Health Up 30% This Past Year, so Why Did One Fund Sell $4 Million in Shares? - AOL.com
Sotera Health (SHC) CFO gets new RSUs as shares withheld for tax - Stock Titan
Sotera Health (SHC) Launches 25 Million Share Secondary Offering - GuruFocus
Form 424B7 Sotera Health Co - StreetInsider
Warburg Pincus and GTCR affiliates to sell 25M Sotera Health shares - Stock Titan
SHC SEC FilingsSotera Health Co 10-K, 10-Q, 8-K Forms - Stock Titan
SHC Stock Price and Chart — NASDAQ:SHC - TradingView
Sotera Health Company (SHC) Stock Analysis: Exploring a 30% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Sotera Health (SHC) Loses 13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz
Assessing Sotera Health (SHC) Valuation After Strong 2025 Results And 2026 Growth Guidance - simplywall.st
Sotera Health (SHC) Is Down 7.1% After Issuing 2026 Revenue Guidance And Marking 20th Growth Year - simplywall.st
SHC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SHC Should I Buy - Intellectia AI
Panel: Investors Failed To Show Sterilization Facility Owner Committed Fraud - Law360
FRAUD AND MANIPULATION—6th Cir.: Sterigenics class action dismissal affirmed by the Sixth Circuit - VitalLaw.com
Sotera Health wins appeal of investor lawsuit - Crain's Cleveland
Sotera Health is Now Oversold (SHC) - Nasdaq
Sotera Prevails in Investor Appeal of Emissions Disclosures Suit - Bloomberg Law News
Sotera Health: Strengthening Fundamentals, Margin Expansion, and Deleveraging Support Buy Rating and $20 Target - TipRanks
Sotera Health Company (NASDAQ:SHC) Q4 2025 Earnings Call Transcript - Insider Monkey
Sotera Health Company (SHC) Stock Analysis: A 16.85% Potential Upside In Healthcare Diagnostics - DirectorsTalk Interviews
Decoding Sotera Health Co (SHC): A Strategic SWOT Insight - GuruFocus
6th Circ. Affirms Dismissal Of Sotera Toxic Gas Investor Suit - Law360
Sotera Health Q4 2025 slides: 20th year of growth, margins hit 51% - Investing.com Australia
SHC: Citigroup Maintains "Buy" Rating, Raises Price Target to $2 - GuruFocus
Sotera Health (SHC) Margin Expansion To 6.7% Tests Premium 60.9x P/E Narrative - simplywall.st
Sotera Health Co (SHC) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges - GuruFocus
SHC Reports Strong Q4 Revenue, Exceeds Expectations - GuruFocus
SHC's Strong Q4 Revenue Surpasses Expectations with Robust Growt - GuruFocus
Sotera Health reports Q4 adjusted EPS 26c, consensus 24c - TipRanks
Sotera Health Q4 2025 slides: 20th year of growth, margins hit 51% By Investing.com - Investing.com South Africa
Sotera Health earnings beat by $0.02, revenue topped estimates - Investing.com Nigeria
Sotera Health Co reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Sotera Health beats Q4 2025 EPS forecasts By Investing.com - Investing.com Canada
Earnings call transcript: Sotera Health beats Q4 2025 EPS forecasts - Investing.com
Sotera Health General Counsel Alex Dimitrief to transition to outside advisor - TipRanks
Sotera Health (NASDAQ:SHC) Issues Quarterly Earnings Results - MarketBeat
Sotera Health (SHC) Announces Leadership Transition in Legal Dep - GuruFocus
Sotera Health Co (SHC) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):